Bridget Martell - Concepedia

Author

Bridget Martell

Yale University

Also Known As

Bridget A. Martell, Bridget Martell, Scholz, Catherine

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Yale University VA Connecticut Healthcare System Memorial Sloan Kettering Cancer Center Denver Health Medical Center University of Michigan

About

Bridget Martell is an author at Yale University specializing in medicine, pharmacotherapy, and pain management.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	417
2	Health Sciences	1	1	174
3	Anesthesia	1	1	14
4	Cell Biology	1	1	23
5	Immunology	1	1	23

Bridget Martell

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma Robert J. Motzer, Thomas E. Hutson, Mark R. Olsen, Journal of Clinical Oncology	2012	275
Cocaine Vaccine for the Treatment of Cocaine Dependence in Methadone-Maintained Patients Bridget Martell, Frank M. Orson, James Poling, Archives of General Psychiatry	2009	261
Vaccine Pharmacotherapy for the Treatment of Cocaine Dependence Bridget Martell, Ellen Siobhan Mitchell, James Poling, Biological Psychiatry Substance AbuseAddiction TreatmentAddictionMedicineAddiction Medicine	2005	206
Tipifarnib in Head and Neck Squamous Cell Carcinoma With<i>HRAS</i>Mutations Alan L. Ho, Irene Braña, Robert I. Haddad, Journal of Clinical Oncology	2021	186
Impact of methadone treatment on cardiac repolarization and conduction in opioid users Bridget Martell, Julia H. Arnsten, Mori J. Krantz, The American Journal of Cardiology Opioid EpidemicSubstance AbuseMethadone TreatmentSubstance UseCardiac Repolarization	2005	174
Six-Month Trial of Bupropion With Contingency Management for Cocaine Dependence in a Methadone-Maintained Population James Poling, Alison Oliveto, Nancy M. Petry, Archives of General Psychiatry	2006	166
Phase II trial of continuous once‐daily dosing of sunitinib as first‐line treatment in patients with metastatic renal cell carcinoma Carlos H. Barrios, David Hernández‐Barajas, Michael P. Brown, Cancer	2011	90
Effects of Methadone on QT‐Interval Dispersion Mori J. Krantz, Christopher M. Lowery, Bridget Martell, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2005	86
Preliminary Data on a Phase 1/2A First in Human Study of the Menin-KMT2A (MLL) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia Eunice S. Wang, Jessica K. Altman, Kristen Pettit, Blood	2020	65
Behavioral effects of γ-hydroxybutyrate in humans Alison Oliveto, W. Brooks Gentry, Rhonda Pruzinsky, Behavioural Pharmacology	2010	30

Page 1